Skip to search formSkip to main contentSkip to account menu

FK 463

Known as: FK-463, FK463 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

MICAFUNGIN SODIUMmicafungin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Candin family antifungal agent micafungin (FK463) modulates the inflammatory cytokine production stimulated by lipopolysaccharide in THP-1 cells.
2006
2006
Candin family antifungal agent micafungin (FK463) modulates the inflammatory cytokine production stimulated by lipopolysaccharide in THP-1 cells
2006
2006
ILVIII-7 Discovery of Micafungin (FK463) : a Novel antifungal drug from Natural Products(Drug Discovery and Developments)
2004
2004
Antifungal characterization of FK463, an inhibitor of 1,3-β-D-glucan synthesis in fungal cell walls
2004
2004
Antifungal Characterization of FK463, an Inhibitor of 1,3-β-D-Glucan Synthesis in Fungal Cell Walls
2003
2003
Eradication of Invasive Mucormycosis--Effectiveness of the Echinocandin FK463
Abstract Background: Invasive rhinocerebral mucormycosis is a rare and often fatal opportunistic fungal infection. It is… 
Review
2002
Review
2002
New agents for the treatment of systemic fungal infections – current status
Systemic antifungal chemotherapy is enjoying its most dynamic era. More antifungal agents are under development than ever before… 
Review
2002
Review
2002
[Issues in the development of drugs for treating deep-seated mycosis].
This review is a collection of abstracts of seven papers presented at the panel discussion Issues in the Development of Drugs for… 
Review
2000
Review
2000
[Invasive fungal infections. Epidemiology and new therapies].
RISING INCIDENCE: In the past two decades, systemic fungal infections, essentially invasive candidiasis, but also invasive… 
Review
2000
Review
2000
40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
The 40th ICAAC was the usual great event with around 15,000 participants and numerous parallel sessions of both oral and poster… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)